Page 1 | Search Results | Hematology, ASH Education Program

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Management of older Hodgkin lymphoma patients

Andrew M. Evens, Jordan Carter, Kah Poh Loh, Kevin A. David

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 233–242.

https://doi.org/10.1182/hematology.2019000028

Published: 2019

Journal Articles

Fixed duration vs continuous therapy in multiple myeloma

Heinz Ludwig, Niklas Zojer

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 212–222.

https://doi.org/10.1182/asheducation-2017.1.212

Published: 2017

Journal Articles

Walking a tightrope: clinical use of ibrutinib in mantle cell lymphoma in the elderly

Marco Ruella, Pierre Soubeyran

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 432–436.

https://doi.org/10.1182/asheducation-2016.1.432

Published: 2016

Journal Articles

Response-adapted frontline therapy for Hodgkin lymphoma: are we there yet?

Peter W. M. Johnson

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 316–322.

https://doi.org/10.1182/asheducation-2016.1.316

Published: 2016

Journal Articles

Maintenance therapy for multiple myeloma in the era of novel agents

Thierry Facon

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 279–285.

https://doi.org/10.1182/asheducation-2015.1.279

Published: 2015

Journal Articles

Double-hit lymphomas: current paradigms and novel treatment approaches

Kieron Dunleavy

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 107–112.

https://doi.org/10.1182/asheducation-2014.1.107

Published: 2014

Journal Articles

Transplantation for mantle cell lymphoma: is it the right thing to do?

Michael E. Williams

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 568–574.

https://doi.org/10.1182/asheducation-2013.1.568

Published: 2013

Journal Articles

Treatment strategies for aggressive lymphomas: what works?

Wyndham H. Wilson

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 584–590.

https://doi.org/10.1182/asheducation-2013.1.584

Published: 2013

Journal Articles

Doublets, triplets, or quadruplets of novel agents in newly diagnosed myeloma?

S. Vincent Rajkumar

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 354–361.

https://doi.org/10.1182/asheducation.V2012.1.354.3798330

Published: 2012

Journal Articles

The Past: What We Have Learned in the Last Decade

Peter Borchmann, Andreas Engert

Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 101–107.

https://doi.org/10.1182/asheducation-2010.1.101

Published: 2010

Journal Articles

Evidence-Based Mini-Review: Is Indium-Labeled Autologous Platelet Scanning Predictive of Response to Splenectomy in Patients With Chronic Immune Thrombocytopenia?

Adam Cuker, Douglas B. Cines

Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 385–386.

https://doi.org/10.1182/asheducation-2010.1.385

Published: 2010

Journal Articles

How to treat elderly patients with multiple myeloma: combination of therapy or sequencing

Antonio Palumbo, Francesca Gay

Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 566–577.

https://doi.org/10.1182/asheducation-2009.1.566

Published: 2009

Journal Articles

Induction Therapy in Multiple Myeloma

Jean-Luc Harousseau

Hematology Am Soc Hematol Educ Program (2008) 2008 (1): 306–312.

https://doi.org/10.1182/asheducation-2008.1.306

Published: 2008

Journal Articles

Antibody Therapy in Aggressive Lymphomas

Thomas M. Habermann

Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 257–264.

https://doi.org/10.1182/asheducation-2007.1.257

Published: 2007

Journal Articles

Initial Therapy of Multiple Myeloma Patients Who Are Not Candidates for Stem Cell Transplantation

Robert Z. Orlowski

Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 338–347.

https://doi.org/10.1182/asheducation-2006.1.338

Published: 2006

Journal Articles

Amyloidosis and Waldenström’s Macroglobulinemia

Morie A. Gertz, Giampaolo Merlini, Steven P. Treon

Hematology Am Soc Hematol Educ Program (2004) 2004 (1): 257–282.

https://doi.org/10.1182/asheducation-2004.1.257

Published: 2004

NARROW

Management of older Hodgkin lymphoma patients

Fixed duration vs continuous therapy in multiple myeloma

Walking a tightrope: clinical use of ibrutinib in mantle cell lymphoma in the elderly

Response-adapted frontline therapy for Hodgkin lymphoma: are we there yet?

Maintenance therapy for multiple myeloma in the era of novel agents

Double-hit lymphomas: current paradigms and novel treatment approaches

Transplantation for mantle cell lymphoma: is it the right thing to do?

Treatment strategies for aggressive lymphomas: what works?

Doublets, triplets, or quadruplets of novel agents in newly diagnosed myeloma?

The Past: What We Have Learned in the Last Decade

Evidence-Based Mini-Review: Is Indium-Labeled Autologous Platelet Scanning Predictive of Response to Splenectomy in Patients With Chronic Immune Thrombocytopenia?

How to treat elderly patients with multiple myeloma: combination of therapy or sequencing

Induction Therapy in Multiple Myeloma

Antibody Therapy in Aggressive Lymphomas

Initial Therapy of Multiple Myeloma Patients Who Are Not Candidates for Stem Cell Transplantation

Amyloidosis and Waldenström’s Macroglobulinemia

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only